J. O’Shaughnessy

Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation

Michele Cottler‐Fox, J. O’Shaughnessy, S Doren et al. · Blood · 1995 · 478 citations

A randomized phase III study of iniparib (BSI-201) in combination with gemcitabine/carboplatin (G/C) in metastatic triple-negative breast cancer (TNBC).

J. O’Shaughnessy, Lee S. Schwartzberg, Michael Danso et al. · Journal of Clinical Oncology · 2011 · 244 citations

Long-term efficacy and safety of addition of carboplatin with or without veliparib to standard neoadjuvant chemotherapy in triple-negative breast cancer: 4-year follow-up data from BrighTNess, a randomized phase III trial

Charles E. Geyer, William M. Sikov, Jens Huober et al. · Annals of Oncology · 2022 · 199 citations · Full text

A randomized study of lapatinib alone or in combination with trastuzumab in heavily pretreated HER2+ metastatic breast cancer progressing on trastuzumab therapy

J. O’Shaughnessy, K. L. Blackwell, Harold J. Burstein et al. · Journal of Clinical Oncology · 2008 · 157 citations

Breast Oncology, Immunology, Pathology +18

Global phase III study of gemcitabine plus paclitaxel (GT) vs. paclitaxel (T) as frontline therapy for metastatic breast cancer (MBC): First report of overall surviva

Kathy S. Albain, S. Nag, G. Calderillo-Ruiz et al. · Journal of Clinical Oncology · 2004 · 155 citations

Overall Surviva, Breast Oncology, Cancer Management +16